Paid Clinical Trials in Santa Rosa, CA
As of August 2026, 112 paid clinical trials are recruiting in Santa Rosa, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Santa Rosa offers studies at sites including Providence Medical Foundation - Santa Rosa for conditions such as Non-Small Cell Lung Cancer, Anatomic Stage II Breast Cancer AJCC v8, Endometrial Cancer, Lung Non-Small Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Santa Rosa
Trials by drug in Santa Rosa
Filter results
111 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Galleri® in the Medicare Population.
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Patient Specific Talus Spacer Post Approval Study
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
Family Communications After Genetic Testing
Top Research Study Locations in Santa Rosa
Researchers run research studies in Santa Rosa, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Medical Foundation - Santa Rosa | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | 30 |
| Kaiser Permanente-Santa Rosa | Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Acute Myeloid Leukemia | 29 |
| Providence Santa Rosa Memorial Hospital | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Ovarian Carcinoma | 26 |
| Sutter Pacific Medical Foundation | Anatomic Stage II Breast Cancer AJCC v8, Metastatic Renal Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma | 18 |
| Providence Medical Foundation | Colorectal Neoplasms, Endometrial Cancer, Fallopian Tube Cancer | 17 |
| NorthBay Clinical Research | Heart Failure, Obesity, Transthyretin Amyloid Cardiomyopathy (ATTR CM) | 3 |
| Providence Medical Group | Anemia, Metastatic Solid Tumors, Myelodysplastic Syndrome | 2 |
| 005 | Diabetic Foot Ulcer | 1 |
| Airway Drive Care Center | Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Central Recruiting Site | Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain, Chemotherapy Induced Pain Neuropathy | 1 |
| GSK Investigational Site | Neoplasms, Solid Tumors | 1 |
| Kaiser Permanente Santa Rosa Emergency Department | Heart Failure | 1 |
| Kaiser Permanente Santa Rosa Med | Lumbar Spinal Stenosis | 1 |
| Laservue Eye Center | Lumbar Spinal Stenosis | 1 |
| NGM Clinical Study Site | CRC (Colorectal Cancer), Cancer Cachexia, Colorectal Cancer | 1 |
| NorthBay Clinical Research LLC | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| NorthBay Clinical Research, LLC | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Northbay Clinical Research Center | Atrial Fibrillation (AF) | 1 |
| Pacific Restorative Center | Lumbar Spinal Stenosis | 1 |
| Providence Medical Foundation (St. Joseph Heritage Healthcare) | Non-small Cell Lung Cancer (NSCLC) | 1 |
| Providence Medical Foundation - Santa Rosa, CA | Metastatic Breast Cancer | 1 |
| Providence Medical Foundation 1 | Carcinoma, Non-Small-Cell Lung | 1 |
| Providence Medical Group - Santa Rosa | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Providence Medical Group Oncology Santa Rosa | Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer, Prostate Cancer | 1 |
Active & Upcoming Studies in Santa Rosa (2026)
Recruiting trials in Santa Rosa grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (82 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Cardiovascular (6 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation · Phase 2 · Regeneron Pharmaceuticals
Diabetes & metabolic (3 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Neurology & pain (2 active studies)
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
- Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain · Phase 2 · Dogwood Therapeutics Inc.
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Common conditions studied in Santa Rosa
- Non-Small Cell Lung Cancer (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Endometrial Cancer (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Acute Myeloid Leukemia (3 active studies)
Leading research sponsors in Santa Rosa
- SWOG Cancer Research Network
- NRG Oncology
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Santa Rosa?
There are approximately 112 recruiting clinical trials in Santa Rosa, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Santa Rosa pay participants?
Most recruiting trials in Santa Rosa compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Santa Rosa?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Santa Rosa?
The most common conditions under active study in Santa Rosa include Non-Small Cell Lung Cancer (5), Anatomic Stage II Breast Cancer AJCC v8 (4), Endometrial Cancer (4), Lung Non-Small Cell Carcinoma (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Santa Rosa?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Santa Rosa on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Santa Rosa?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Santa Rosa?
Recruiting research sites in Santa Rosa include Providence Medical Foundation - Santa Rosa, Kaiser Permanente-Santa Rosa, Providence Santa Rosa Memorial Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Santa Rosa right now?
The largest active categories in Santa Rosa are Cancer & tumors (82), Cardiovascular (6), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.